NCT05303519 2026-03-05
SIGMA
Nuvation Bio Inc.
Phase 3 Recruiting
Clinical Trials
4 trialsNCT06666712 2026-01-13
TPT CED rHGG
Columbia University
Phase 1 Recruiting
NCT04094610 2025-11-19
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Turning Point Therapeutics, Inc.
Phase 1/2 Recruiting
NCT07198256 2025-09-30
AI-assisted Diagnosis of Malignant Brain Tumors
Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting